Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award - PA - Bioinformatics and Computational Biology

Direct Payment

$120,000.00

Deciphering Immunoresistance in Pancreatic Ductal Adenocarcinoma Using Perturb-Map and Single-Cell Spatial Transcriptomics

FY 2024-25

Summary
Pancreatic Ductal Adenocarcinoma (PDAC) is an aggressive cancer that is expected to become the second leading cause of cancer deaths by 2030. PDAC tumors are notoriously difficult to treat with immunotherapy due to the presence of cancer-associated fibroblasts (CAFs), which create a protective barrier around the tumor and block immune cells from infiltrating. My research aims to understand how cancer cells manipulate CAFs to promote tumor growth and evade the immune system. To do this, I will use a cutting-edge tool called Perturb-map, which allows us to knock out genes in cancer cells and study their effects on the tumor's spatial environment. In preliminary research, I identified two key genes, Serpine1 and Serpinb2, that, when knocked out, reduced tumor growth and weakened the protective CAF barrier, allowing immune cells to infiltrate the tumor. Based on this data, I hypothesize that cancer cells use specific genes to control CAFs, creating a "cold" tumor microenvironment that is resistant to immune attack. Using single-cell and spatial-transriptomic data, I have identified 56 candidate genes which are predicted to mobilize CAFs and promote tumor protection. To test my hypothesis and gain further insight into how the PDAC microenvironment is controlled, I will carry out two specific aims. First, I will conduct a Perturb-map screen with spatial transcriptomics to understand the role of these 56 genes when they are knocked out in mice. I will determine how these genes impact tumor growth, immune cell infiltration, and whether they result in CAF polarization or reduction. Second, I will target cancer cell-CAF interactions that result in CAF-driven immunoresistance using blocking antibodies to mechanistically identify the key targetable pathways driving CAF protection of cancer cells. Successful completion of this work will provide us with candidate genes to target CAF-driven cancer cell protection in patients with treatment-resistant PDAC.
Program
Doctoral Research Award - PA - Bioinformatics and Computational Biology
Location
New York, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
517747
Name
Singh Bhavya
Region
New York
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Deciphering Immunoresistance in Pancreatic Ductal Adenocarcinoma Using Perturb-Map and Single-Cell Spatial Transcriptomics
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award - PA - Bioinformatics and Computational Biology
Keyworddelim
Cancer-Associated Fibroblasts; Fibrinolysis; Immunoresistance; Multiplexed Imaging; Pancreatic Ductal Adenocarcinoma; Perturb-Map; Single-Cell Rna Sequencing; Spatial Omics; Spatial Transcriptomics; Tumor Microenvironment
Abstract
Pancreatic Ductal Adenocarcinoma (PDAC) is an aggressive cancer that is expected to become the second leading cause of cancer deaths by 2030. PDAC tumors are notoriously difficult to treat with immunotherapy due to the presence of cancer-associated fibroblasts (CAFs), which create a protective barrier around the tumor and block immune cells from infiltrating. My research aims to understand how cancer cells manipulate CAFs to promote tumor growth and evade the immune system. To do this, I will use a cutting-edge tool called Perturb-map, which allows us to knock out genes in cancer cells and study their effects on the tumor's spatial environment. In preliminary research, I identified two key genes, Serpine1 and Serpinb2, that, when knocked out, reduced tumor growth and weakened the protective CAF barrier, allowing immune cells to infiltrate the tumor. Based on this data, I hypothesize that cancer cells use specific genes to control CAFs, creating a "cold" tumor microenvironment that is resistant to immune attack. Using single-cell and spatial-transriptomic data, I have identified 56 candidate genes which are predicted to mobilize CAFs and promote tumor protection. To test my hypothesis and gain further insight into how the PDAC microenvironment is controlled, I will carry out two specific aims. First, I will conduct a Perturb-map screen with spatial transcriptomics to understand the role of these 56 genes when they are knocked out in mice. I will determine how these genes impact tumor growth, immune cell infiltration, and whether they result in CAF polarization or reduction. Second, I will target cancer cell-CAF interactions that result in CAF-driven immunoresistance using blocking antibodies to mechanistically identify the key targetable pathways driving CAF protection of cancer cells. Successful completion of this work will provide us with candidate genes to target CAF-driven cancer cell protection in patients with treatment-resistant PDAC.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Singh, Bhavya
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~
Direct Payment - $120,000 Grant (2024-25) | Canada Spends